Early therapy monitoring with FDG-PET in aggressive non-Hodgkin?s lymphoma and Hodgkin?s lymphoma

This publication has 27 references indexed in Scilit:

• PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.
  2002
• Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.
  2001
• Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
  1999
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995
• In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
  1995
• A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin’s lymphomas: Updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy
  Published by Springer Nature ,1991
• Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease
  Radiotherapy and Oncology, 1988